Phathom Pharmaceuticals (PHAT) EPS (Basic) (2018 - 2026)
Phathom Pharmaceuticals (PHAT) posted quarterly EPS (Basic) of -$0.33 for Q2 2026, up 70.96% year-over-year from -$0.2 in Q2 2025, and up 42.82% quarter-over-quarter from -$0.58 in Q1 2026.
Powered by 
Analysis
Phathom Pharmaceuticals (PHAT) EPS (Basic) (2018 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has reported EPS (Basic) for 9 consecutive years, with -$0.33 the latest figure, recorded in Q2 2026.
- In Q2 2026, EPS (Basic) rose 70.96% year-over-year to -$0.33; the TTM figure through Jun 2026 stood at -$1.82 (up 58.31% YoY), while the FY2025 annual figure was -$6.29, up 23.25% from the prior year.
- EPS (Basic) advanced to -$0.33 in Q2 2026 per PHAT's latest filing, from -$0.58 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.29 in Q4 2025 and bottomed at -$1.87 in Q4 2023.
- Historically, EPS (Basic) has averaged -$1.05 across 5 years, with a median of -$1.11 in 2022.
- On a YoY basis, EPS (Basic) climbed as much as 83.25% in 2024 and fell as far as 142.26% in 2024.
- Phathom Pharmaceuticals' EPS (Basic) stood at -$1.21 in 2022, then tumbled by 54.14% to -$1.87 in 2023, then jumped by 83.25% to -$0.31 in 2024, then climbed by 7.41% to -$0.29 in 2025, then dropped by 15.29% to -$0.33 in 2026.
- Business Quant data shows PHAT's EPS (Basic) at -$0.33 in Q2 2026, -$0.58 in Q1 2026, and -$0.29 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Phathom Pharmaceuticals | 796.85 Mn | 611.51 Mn | 59.18 Mn | -0.21 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.21 |
| Mar 31, 2026 | -0.36 |
| Dec 31, 2025 | -0.29 |
| Sep 30, 2025 | -0.41 |
| Jun 30, 2025 | -1.04 |
| Mar 31, 2025 | -1.31 |
| Dec 31, 2024 | -1.18 |
| Sep 30, 2024 | -1.32 |
| Jun 30, 2024 | -1.56 |
| Mar 31, 2024 | -1.42 |
| Dec 31, 2023 | -1.55 |
| Sep 30, 2023 | -0.76 |
| Jun 30, 2023 | -0.84 |
| Mar 31, 2023 | -0.89 |
| Dec 31, 2022 | -1.40 |
| Sep 30, 2022 | -1.32 |
| Jun 30, 2022 | -1.33 |
| Mar 31, 2022 | -1.07 |
| Dec 31, 2021 | -0.97 |
| Sep 30, 2021 | -0.93 |